|
US4609675A
(en)
|
1984-08-17 |
1986-09-02 |
The Upjohn Company |
Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
|
|
BR8701121A
(pt)
|
1986-03-12 |
1988-01-05 |
Glaxo Group Ltd |
Processo para a preparacao de um composto e processo para combate a pestes
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5773647A
(en)
|
1997-02-07 |
1998-06-30 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
EP1061946B1
(en)
|
1998-02-27 |
2004-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
|
JP2002506792A
(ja)
|
1998-02-27 |
2002-03-05 |
ノボ ノルディスク アクティーゼルスカブ |
Ｎ末端修飾ｇｌｐ−１誘導体
|
|
AU3247799A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
WO1999043706A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Derivatives of glp-1 analogs
|
|
SE9802080D0
(sv)
|
1998-06-11 |
1998-06-11 |
Hellstroem |
Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
|
|
AU3357800A
(en)
|
1999-02-05 |
2000-08-25 |
Emisphere Technologies, Inc. |
Method of preparing alkylated salicylamides
|
|
WO2000048589A1
(en)
|
1999-02-22 |
2000-08-24 |
Emisphere Holdings, Inc. |
Solid oral dosage form containing heparin or a heparinoid in combination with a carrier
|
|
WO2000050012A1
(en)
|
1999-02-22 |
2000-08-31 |
Elan Corporation, Plc |
Solid oral dosage form containing an enhancer
|
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
|
GB9923436D0
(en)
|
1999-10-04 |
1999-12-08 |
American Home Prod |
Pharmaceutical compositions
|
|
US6793934B1
(en)
|
1999-12-08 |
2004-09-21 |
Shire Laboratories, Inc. |
Solid oral dosage form
|
|
AU2001275231A1
(en)
|
2000-06-02 |
2001-12-11 |
Emisphere Technologies, Inc. |
Method of preparing salicylamides
|
|
US7049283B2
(en)
|
2000-12-06 |
2006-05-23 |
Novartis Ag |
Pharmaceutical compositions for the oral delivery of pharmacologically active agents
|
|
NZ528543A
(en)
|
2001-03-27 |
2005-07-29 |
Ranbaxy Lab Ltd |
A stable pharmaceutical composition of pravastatin and a carrier
|
|
CZ20033116A3
(cs)
|
2001-05-15 |
2004-09-15 |
Warner-Lambert Company Llc |
Způsob výroby lékové formy fenytoinu sodného užívající kompaktor
|
|
US20030068356A1
(en)
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
|
AU2002352974A1
(en)
|
2001-11-29 |
2003-06-10 |
Emisphere Technologies, Inc. |
Formulations for oral administration of cromolyn sodium
|
|
JP2005526020A
(ja)
|
2002-02-01 |
2005-09-02 |
ファイザー・プロダクツ・インク |
アジスロマイシンの乾式造粒配合物
|
|
CN1332711C
(zh)
|
2002-02-20 |
2007-08-22 |
埃米球科技有限公司 |
施用glp－1分子的方法
|
|
JP2004131398A
(ja)
*
|
2002-10-08 |
2004-04-30 |
Taihei Chemical Industrial Co Ltd |
錠剤用滑沢剤
|
|
AU2004241242A1
(en)
|
2003-05-14 |
2004-12-02 |
Emisphere Technologies, Inc. |
Compositions for delivering peptide YY and PYY agonists
|
|
PT1651248E
(pt)
|
2003-07-11 |
2009-11-10 |
Novartis Ag |
Composições farmacêuticas para dose oral compreendendo um agente de administração na forma micronizada
|
|
CA2539253A1
(en)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
AU2004298424A1
(en)
|
2003-12-18 |
2005-06-30 |
Novo Nordisk A/S |
Novel GLP-1 compounds
|
|
BRPI0417684A
(pt)
|
2003-12-18 |
2007-03-20 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
WO2005099672A1
(en)
|
2004-04-13 |
2005-10-27 |
Ranbaxy Laboratories Limited |
A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
|
|
AU2005240206B2
(en)
*
|
2004-05-06 |
2011-04-07 |
Emisphere Technologies, Inc. |
Solid dosage form of wetted heparin
|
|
SG153039A1
(en)
|
2004-05-06 |
2009-06-29 |
Emisphere Tech Inc |
Crystalline polymorphic forms of monosodium n-[8- (2hydroxybenzoyl)amino]caprylate
|
|
NZ551196A
(en)
|
2004-05-14 |
2010-08-27 |
Emisphere Tech Inc |
Compounds and compositions for delivering active agents
|
|
CN1767818A
(zh)
|
2004-05-31 |
2006-05-03 |
三亚药品株式会社 |
含β－内酰胺抗生素的分散片剂及其制备方法
|
|
CN101010339B
(zh)
|
2004-07-02 |
2011-11-09 |
布里斯托尔-迈尔斯斯奎布公司 |
人类胰高血糖素样肽-1调节剂及它们在治疗糖尿病及相关病况中的用途
|
|
ES2542228T3
(es)
|
2004-07-08 |
2015-08-03 |
Novo Nordisk A/S |
Marcas de prolongación polipeptídica que comprenden un resto de tetrazol
|
|
JP2008509933A
(ja)
*
|
2004-08-13 |
2008-04-03 |
エミスフェアー・テクノロジーズ・インク |
送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤
|
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
|
JP5107713B2
(ja)
|
2004-10-07 |
2012-12-26 |
ノヴォ ノルディスク アー／エス |
遅延性のエキセンディン−４化合物
|
|
EP2586444B1
(en)
|
2004-12-03 |
2019-09-25 |
Merck Sharp & Dohme Corp. |
Pharmaceutical formulation of carboxamide HIV integrase inhibitors containing a release rate control composition
|
|
US20080153779A1
(en)
*
|
2005-02-01 |
2008-06-26 |
Jun Liao |
Gastric Retention and Controlled Release Delivery System
|
|
TWI372629B
(en)
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
BRPI0608516A2
(pt)
|
2005-03-18 |
2010-11-16 |
Novo Nordisk As |
análogo de glp-1, método para aumentar o tempo de ação em um paciente de um análogo de glp-1, composição farmacêutica, e, uso de um composto
|
|
EP1863449A2
(en)
|
2005-03-28 |
2007-12-12 |
Dexcel Pharma Technologies Ltd. |
Controlled absorption of statins in the intestine
|
|
US20070049557A1
(en)
|
2005-08-24 |
2007-03-01 |
Hashim Ahmed |
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
|
|
US20080255048A1
(en)
|
2005-11-17 |
2008-10-16 |
Moise Azria |
Pharmaceutical Composition
|
|
ES2426445T3
(es)
|
2006-04-07 |
2013-10-23 |
Merrion Research Iii Limited |
Forma de dosificación oral sólida que contiene un potenciador
|
|
US8927015B2
(en)
|
2006-04-12 |
2015-01-06 |
Emisphere Technologies, Inc. |
Formulations for delivering insulin
|
|
CA2654566A1
(en)
|
2006-06-09 |
2007-12-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
|
US9364502B2
(en)
*
|
2006-06-28 |
2016-06-14 |
Emisphere Technologies, Inc. |
Gallium nitrate formulations
|
|
ES2296529B1
(es)
|
2006-08-07 |
2009-04-01 |
Laboratorios Farmaceuticos Rovi, S.A. |
Composicion farmaceutica con promotores de absorcion.
|
|
US20090318353A1
(en)
|
2006-08-25 |
2009-12-24 |
Novo Nordisk A/S |
Acylated Exendin-4 Compounds
|
|
KR101081149B1
(ko)
|
2006-09-07 |
2011-11-07 |
에미스페어 테크놀로지스, 인코포레이티드 |
Ｓｎａｃ(살카프로제이트 나트륨)의 제조 방법
|
|
AR062925A1
(es)
|
2006-09-22 |
2008-12-17 |
Novartis Ag |
Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
|
|
US20100069410A1
(en)
*
|
2006-12-01 |
2010-03-18 |
Emisphere Technologies Inc. |
acyclovir formulations
|
|
ES2365648T3
(es)
|
2007-03-02 |
2011-10-07 |
Novartis Ag |
Administración oral de una calcitonina.
|
|
CA2697504A1
(en)
|
2007-08-29 |
2009-03-12 |
The Regents Of The University Of California |
Salicylanilide modified peptides for use as oral therapeutics
|
|
ES2672770T3
(es)
|
2007-09-05 |
2018-06-18 |
Novo Nordisk A/S |
Derivados del péptido-1 similar al glucagón y su uso farmacéutico
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
US20100292133A1
(en)
|
2007-09-05 |
2010-11-18 |
Novo Nordisk A/S |
Truncated glp-1 derivaties and their therapeutical use
|
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
|
WO2009059188A1
(en)
|
2007-11-02 |
2009-05-07 |
Emisphere Technologies, Inc. |
Method of treating vitamin b12 deficiency
|
|
US20090124639A1
(en)
|
2007-11-06 |
2009-05-14 |
Emisphere Technologies Inc. |
valacyclovir formulations
|
|
US20100317057A1
(en)
|
2007-12-28 |
2010-12-16 |
Novo Nordisk A/S |
Semi-recombinant preparation of glp-1 analogues
|
|
CN102123697B
(zh)
|
2008-08-18 |
2015-06-10 |
安特拉贝欧有限公司 |
用于口服给予蛋白质的方法和组合物
|
|
AU2010212823B2
(en)
|
2009-02-13 |
2016-01-28 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications comprising a DPP-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
|
|
JP2013514976A
(ja)
|
2009-12-16 |
2013-05-02 |
ノッド ファーマシューティカルズ， インコーポレイテッド |
経口薬物送達のための組成物および方法
|
|
US20110182985A1
(en)
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
|
WO2011116139A2
(en)
|
2010-03-16 |
2011-09-22 |
Chiasma Inc. |
Improved pharmaceutical compositions and methods of delivery
|
|
BR112012026255A2
(pt)
|
2010-04-07 |
2017-03-14 |
Vertex Pharma |
composições farmacêuticas de ácido 3-(6-(1-(2-,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e administração das mesmas
|
|
KR101927068B1
(ko)
|
2010-05-05 |
2018-12-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
|
|
DE202010015867U1
(de)
|
2010-11-25 |
2011-05-05 |
Buchhalter, Thomas |
Elektromechanische Halterung zur Aufnahme von Navigations- und Kommunikationsgeräte im KFZ
|
|
MX345501B
(es)
|
2010-12-16 |
2017-02-02 |
Novo Nordisk As |
Composiciones solidas que comprenden agonista de glp-1 y sal del acido n-(8-(2-hidroxibenzoil)amino)caprilico.
|
|
WO2013139695A1
(en)
|
2012-03-22 |
2013-09-26 |
Novo Nordisk A/S |
Compositions comprising a delivery agent and preparation thereof
|
|
EP2827885B1
(en)
|
2012-03-22 |
2018-08-15 |
Novo Nordisk A/S |
Compositions of glp-1 peptides and preparation thereof
|
|
US9993430B2
(en)
|
2012-06-20 |
2018-06-12 |
Novo Nordisk A/S |
Tablet formulation comprising semaglutide and a delivery agent
|
|
SMT201800492T1
(it)
|
2013-05-02 |
2018-11-09 |
Novo Nordisk As |
Dosaggio orale di composti di glp-1
|